NIH-funded research R01 grant

Programmable stem cells to improve survival and therapy in damaged tissues

Official title: Reinvent Mesenchymal Stem Cells - A Synthetic Biology Approach to Engineer Programmable Cellular Theranostics

Funded at University of South Dakota · NIH-11267049 · Data updated 2026-11-12

Researchers are developing engineered mesenchymal stem cells that can sense stress in damaged tissues and respond with protective signals to boost healing.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of South Dakota
NIH-funded
Lab location1 site (Vermillion, United States)
Project startJune 1, 2026
Project endMay 31, 2030
Funding year2026
Award (this year)$2,799,643
NIH project number1R01EB038224-01
Project IDNIH-11267049 on NIH RePORTER

Who could benefit from this research

Could help

Adults with tissue injury or degenerative conditions who are candidates for stem cell therapies and can participate in future translational research.

Less likely to help

This early-stage work is preclinical and may not directly benefit all patients; regulatory and safety steps are required before clinical use.

What this research studies

This grant aims to create programmable mesenchymal stem cells that survive better in harsh tissue environments by using synthetic gene circuits to sense stress and trigger beneficial responses. The project will integrate autonomous control mechanisms to ensure safety and targeted action, with the goal of enhancing regenerative outcomes. If successful, these aiMSCs could become a new cellular therapy approach for diseases involving tissue damage in adults.

Why it matters

Potential benefit: Patients with damaged or diseased tissues could experience improved healing and regeneration through safer, more effective stem cell therapies.

How similar studies have gone: Preclinical studies with engineered stem cells have shown promise in improving cell survival and function in hostile microenvironments, supporting continued development.

Where this research is happening

  • University of South Dakota
    Vermillion, United States
    Active

Researchers

  • Principal investigator: Chen, William C.w. — University of South Dakota
  • Study coordinator: Chen, William C.w.

Related research

Other NIH-funded projects on the same topics.

  • Boosting the cell cleanup system to protect against aging and Alzheimer's

    Researchers will see whether changing a tiny chemical switch on the cell's protein-cleaning machinery helps prevent aging-related damage and Alzheimer's changes in the brain and heart.

    NIH research University of South Dakota · Vermillion, United States · NIH-11297483

  • Understanding how heart cells control protein disposal to prevent heart failure

    A research project from the University of South Dakota aims to learn how the heart’s protein disposal system works during ischemic heart disease to help prevent heart failure.

    NIH research University of South Dakota · Vermillion, United States · NIH-11248064

  • Mobile web app to increase cervical cancer screening for Yankton Sioux women

    A culturally tailored mobile web app will send personalized messages to help Yankton Sioux women ages 25–65 stay up to date with cervical cancer screening.

    NIH research University of South Dakota · Vermillion, United States · NIH-11170413

  • Using brain growth signals to help memory and thinking

    Testing lab-designed versions of the hormone erythropoietin that keep its brain-helping effects but not the blood effects, to help people with memory and attention problems.

    NIH research University of South Dakota · Vermillion, United States · NIH-11127435

  • South Dakota INBRE: Growing Biomedical Research in SD

    A statewide program builds biomedical research capacity in South Dakota by supporting training, collaboration, and shared core resources across universities.

    NIH research University of South Dakota · Vermillion, United States · NIH-11093670

  • Targeting HIV reservoirs in the brain to improve treatment outcomes

    This study is looking for new ways to help people with HIV by targeting hidden spots in the brain where the virus can still hide, even when they're on treatment, and it focuses on understanding how certain proteins can help in this process.

    NIH research University of South Dakota · Vermillion, United States · NIH-11081715

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.